Improving prostate cancer diagnosis using advanced ultrasound techniques
Prostate Cancer Diagnosis by Multiparametric Ultrasound
This study is testing a new type of ultrasound to help doctors find serious prostate cancer more accurately and affordably, so patients can get the right treatment without unnecessary procedures for less aggressive cases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10910108 on NIH RePORTER |
What this research studies
This research focuses on enhancing the diagnosis of prostate cancer by utilizing advanced ultrasound methods, specifically contrast-enhanced ultrasound (CEUS). The goal is to identify clinically significant prostate cancer more accurately and cost-effectively than current methods, such as multiparametric MRI. By employing innovative imaging techniques like subharmonic imaging and dispersion imaging, the research aims to reduce the number of missed aggressive cancer cases and minimize unnecessary treatments for non-aggressive cancers. Patients will undergo ultrasound imaging to assess the presence of significant prostate cancer lesions.
Who could benefit from this research
Good fit: Ideal candidates for this research are men who are at risk for prostate cancer and may require diagnostic imaging to determine the aggressiveness of their condition.
Not a fit: Patients with low-risk prostate cancer who do not require further diagnostic intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and less invasive prostate cancer diagnoses, reducing overtreatment and improving patient outcomes.
How similar studies have performed: Previous studies have shown promise in using advanced ultrasound techniques for cancer detection, indicating that this approach may lead to significant advancements in prostate cancer diagnosis.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Forsberg, Flemming — Thomas Jefferson University
- Study coordinator: Forsberg, Flemming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.